Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation Suspension.

MLA

Ali, Juzar, et al. “Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation Suspension.” Pulmonary Therapy, vol. 10, no. 3, Sept. 2024, pp. 315–30. EBSCOhost, https://doi.org/10.1007/s41030-024-00263-1.

APA

Ali, J., Wu, J., Hassan, M., Tsai, J.-H., Touba, N., McCarrier, K., Ballard, M., & Chatterjee, A. (2024). Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation Suspension. Pulmonary Therapy, 10(3), 315–330. https://doi.org/10.1007/s41030-024-00263-1

Chicago

Ali, Juzar, Jasmanda Wu, Mariam Hassan, Jui-Hua Tsai, Nancy Touba, Kelly McCarrier, Mark Ballard, and Anjan Chatterjee. 2024. “Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation Suspension.” Pulmonary Therapy 10 (3): 315–30. doi:10.1007/s41030-024-00263-1.